Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Change in Accured Expenses (2016 - 2018)

Armata Pharmaceuticals' Change in Accured Expenses history spans 6 years, with the latest figure at -$371000.0 for Q4 2018.

  • For Q4 2018, Change in Accured Expenses fell 52.67% year-over-year to -$371000.0; the TTM value through Dec 2018 reached $144000.0, up 117.18%, while the annual FY2024 figure was $1.5 million, 3776.92% up from the prior year.
  • Change in Accured Expenses for Q4 2018 was -$371000.0 at Armata Pharmaceuticals, down from $648000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.3 million in Q3 2014 and bottomed at -$1.6 million in Q4 2014.
  • The 5-year median for Change in Accured Expenses is -$182500.0 (2015), against an average of -$86687.5.
  • The largest annual shift saw Change in Accured Expenses crashed 280.37% in 2014 before it surged 25850.0% in 2017.
  • A 5-year view of Change in Accured Expenses shows it stood at -$1.6 million in 2014, then surged by 92.54% to -$122000.0 in 2015, then surged by 255.74% to $190000.0 in 2016, then plummeted by 227.89% to -$243000.0 in 2017, then crashed by 52.67% to -$371000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Change in Accured Expenses are -$371000.0 (Q4 2018), $648000.0 (Q3 2018), and $222000.0 (Q2 2018).